[Pembrolizumab and Cetuximab as therapeutic options for ACC in head and neck].
Michaelides I, Fest S, Berszin M, Wiegand S, Bohr C, Künzel J, Dietz A, Pirlich M, Wichmann G.
Michaelides I, et al. Among authors: dietz a.
Laryngorhinootologie. 2022 Sep;101(9):736-740. doi: 10.1055/a-1830-8298. Epub 2022 May 16.
Laryngorhinootologie. 2022.
PMID: 35576974
German.
No abstract available.